Does Bariatric Surgery Reduce the Risk of Colorectal Cancer in Individuals with Morbid Obesity? A Systematic Review and Meta-Analysis.
Andrea ChiericiPaolo AmorettiCéline DraiSerena De FaticoJérôme BarriereLuigi SchiavoAntonio IannelliPublished in: Nutrients (2023)
Bariatric surgery has shown to be effective in producing sustained weight loss and the resolution of obesity related medical problems. Recent research focused on the role of obesity and adipose tissue in tumorigenesis, finding a strong crosslink through different mechanisms and highlighting an increase in cancer incidence in individuals with obesity. The aim of this meta-analysis is to find if bariatric surgery reduces the incidence of colorectal cancer in patients with obesity. We performed a meta-analysis including 18 studies (PROSPERO ID: CRD4202235931). Bariatric surgery was found to be significantly protective toward colorectal cancer incidence in individuals with obesity (HR: 0.81, p = 0.0142). The protective effect persisted when considering women (RR: 0.54, p = 0.0014) and men (RR: 0.74, p = 0.2798) separately, although this was not significant for the latter. No difference was found when comparing Roux-en-Y gastric bypass and sleeve gastrectomy. Bariatric surgery reduces the incidence of colorectal cancer in individuals with obesity independently from gender and surgical procedure. Prospective large cohort studies are needed to confirm these findings.
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- obese patients
- gastric bypass
- insulin resistance
- adipose tissue
- weight gain
- metabolic syndrome
- systematic review
- risk factors
- glycemic control
- type diabetes
- high fat diet induced
- randomized controlled trial
- mental health
- high fat diet
- squamous cell carcinoma
- pregnant women
- drug induced
- meta analyses